Ayala eyes completion of specialty cancer hospital in Taguig by mid-2023
Conglomerate Ayala Corp. said the country’s first comprehensive cancer specialty hospital in Taguig passed the “midway” construction milestone, with full completion seen by the middle of 2023.
Once finished, the 100-bed Healthway Cancer Care Hospital in Ayala’s Arca South project would offer “quality, accessible and affordable cancer services to a broader base of Filipinos.”
In a statement on Tuesday, Paolo Borromeo, president and CEO of Ayala Healthcare Holdings (AC Health), said they were expecting the first major delivery of cancer equipment by the end of 2022.
This followed an agreement last August between AC Health and Siemens Healthineers, a leading global provider of healthcare systems.
The partnership will provide the 100-bed cancer hospital with technical expertise and technologies in diagnostic and therapeutic imaging, Ayala said.
The project forms part of Ayala’s P10-billion healthcare investment.
Article continues after this advertisementIt will offer a complete range of services from screening, diagnosis, treatment to post-cancer care. It will be equipped with chemotherapy chairs, operating theaters, and state-of-the-art diagnostic and therapeutic equipment.
Article continues after this advertisement“We are excited to see the plans for the hospital come to fruition and are incredibly thankful for the tremendous support we are receiving from more and more medical practitioners, patients, and communities,” Borromeo said.
AC Health’s portfolio includes Generika Drugstore retail pharmacies, IE Medica and MedEthix, major pharmaceutical importer and distributor, Healthway multi-specialty and corporate clinics, and QualiMed, a comprehensive network of full-service hospitals, multi-specialty clinics, and a stand-alone day surgery center.
The company also invested in health technology solutions via the HealthNow app, which offers online consultations, medicine delivery, and clinic and diagnostic booking.
Last April, Ayala said it planned to achieve profitability for its healthcare group by 2022 and reach a net income of P1 billion by 2025.
